In light of the high proliferation rate of SCLC tumors and the almost universal bi-allelic loss of both tumor suppressor genes, TP53 and RB12,3, we sought to further characterize the transcriptional profile of SCLC in comparison to other major lung cancer subtypes. This evidence concerns the gene TP53 and neoplasm.